These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1716762)

  • 1. Cu/Zn superoxide dismutase quantification from fetal erythrocytes--an efficient confirmatory test for Down's syndrome after maternal serum screening and sonographic investigations.
    Porstmann T; Wietschke R; Cobet G; Stamminger G; Bollmann R; Rogalski V; Pas P
    Prenat Diagn; 1991 May; 11(5):295-303. PubMed ID: 1716762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical quantification of Cu/Zn superoxide dismutase in prenatal diagnosis of Down's syndrome.
    Porstmann T; Wietschke R; Cobet G; Lorenz K; Grunow R; Jahn S; Bollmann R; Stamminger G; von Baehr R
    Hum Genet; 1990 Aug; 85(3):362-6. PubMed ID: 2144256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alphafetoprotein in midtrimester Down's syndrome fetal serum.
    Seller MJ
    J Med Genet; 1990 Apr; 27(4):240-3. PubMed ID: 1691297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoplasia of the middle phalanx of the fifth digit. A feature of the second trimester fetus with Down's syndrome.
    Benacerraf BR; Harlow BL; Frigoletto FD
    J Ultrasound Med; 1990 Jul; 9(7):389-94. PubMed ID: 2142738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The second-trimester fetal iliac angle as a sign of Down's syndrome.
    Shipp TD; Bromley B; Lieberman E; Benacerraf BR
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):15-8. PubMed ID: 9697278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    Wald NJ; Watt HC; Hackshaw AK
    N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and sensitive enzyme immunoassay for Cu/Zn superoxide dismutase with polyclonal and monoclonal antibodies.
    Porstmann T; Wietschke R; Schmechta H; Grunow R; Porstmann B; Bleiber R; Pergande M; Stachat S; von Baehr R
    Clin Chim Acta; 1988 Jan; 171(1):1-10. PubMed ID: 2964951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal cephalometry by ultrasound as a screening procedure for the prenatal detection of Down's syndrome.
    Perry TB; Benzie RJ; Cassar N; Hamilton EF; Stocker J; Toftager-Larsen K; Lippman A
    Br J Obstet Gynaecol; 1984 Feb; 91(2):138-43. PubMed ID: 6230100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
    Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
    Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down's syndrome screening with nuchal translucency at 12(+0)-14(+0) weeks and maternal serum markers at 14(+1)-17(+0) weeks: a prospective study.
    Rozenberg P; Malagrida L; Cuckle H; Durand-Zaleski I; Nisand I; Audibert F; Benattar C; Tribalat S; Cartron M; Lemarié P; Stoessel J; Capolagui P; Jansé-Marec J; Barbier D; Allouch C; Perdu M; Roberto A; Lahna Z; Giudicelli Y; Ville Y
    Hum Reprod; 2002 Apr; 17(4):1093-8. PubMed ID: 11925411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.